TrialBMC cancer2014

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.

Sophie Lehn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.